| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb35225a578542c5592310a91d18f18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572 |
| filingDate |
2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0880e279b5b034cb443f629c03da6ca2 |
| publicationDate |
2009-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200944537-A |
| titleOfInvention |
Formulations comprising a phosphoindole compound and one or more second active agents |
| abstract |
Provided herein are pharmaceutical compositions of a phosphoindole compound that can have advantageous release properties. The pharmaceutical compositions can comprise a phosphoindole compound and one or more polyglycolyzed glycerides. The pharmaceutical compositions can be useful for inhibiting viral replication. The pharmaceutical compositions provided herein can also be useful, for example, for the treatment of viral infection such as human immunodeficiency virus infection. |
| priorityDate |
2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |